Practice of non-pharmaceutical interventions against COVID-19 and reduction of the risk of influenza-like illness: a cross-sectional population-based study
| dc.rights.license | open | en_US |
| hal.structure.identifier | Institut de Santé Publique, d'Epidémiologie et de Développement [ISPED] | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | YOUSSEF, Dalal | |
| dc.contributor.author | ISSA, Ola | |
| dc.contributor.author | KANSO, Maysaloun | |
| dc.contributor.author | YOUSSEF, Janet | |
| dc.contributor.author | ABOU-ABBAS, Linda | |
| dc.contributor.author | ABBOUD, Edmond | |
| dc.date.accessioned | 2022-10-31T08:03:10Z | |
| dc.date.available | 2022-10-31T08:03:10Z | |
| dc.date.issued | 2022-08-30 | |
| dc.identifier.issn | 2052-3211 (Print) 2052-3211 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/170163 | |
| dc.description.abstractEn | INTRODUCTION: While the widespread implementation of the non-pharmaceutical interventions was intended to contain the COVID-19 pandemic, such measures could be also effective in limiting the spread of other respiratory infections. This study aimed to examine the association between the implementation of personal protective measures and the occurrence of influenza-like illnesses (ILI) in the general population. METHODS: An online retrospective cross-sectional observational study was conducted in April 2021 to assess cases of ILI among Lebanese adults aged 18 years and above, from all Lebanese governorates during the 2020-2021 flu season. Data were collected using a convenience sampling method. In addition to their socio-demographic information, participants were asked about their frequency of implementing personal protective measures and if they have experienced symptoms of ILI in the previous 6 months. The overall score of the personal protective measures was computed. Multivariable logistic regression was performed to examine the association between participants' level of adoption of personal protective measures against COVID-19 and the occurrence of ILI. RESULTS: Among the 1019 Lebanese adults participating in this study, 352 (34.54%) of them reported symptoms of ILI between October 2020 and March 2021. Lebanese adults who wore their facemasks frequently or always were less likely to suffer from symptoms of ILI than others who did not wear the mask (aOR = 0.452, 95% CI = 0.349-0.693, p < 0.001). Similarly, adults who adopt the following protective measures washing hands (aOR = 0.608, 95% CI = 0.524-0.922, p < 0.001), respecting cough etiquette (aOR = 0.763, 95% CI = 0.598-0.918, p < 0.001), disinfecting surface (aOR = 0.892, 95% CI = 0.632-0.911, p = 0.012), avoiding crowded places (aOR = 0.739, 95% CI = 0.688-0.903, p = 0.049), respecting physical distancing (aOR = 0.646, 95% CI = 0.482-0.833, p = 0.031) on a regular basis (frequently/always) were less likely to report symptoms of influenza-like illnesses when compared with those who did not adhere at all to these measures. CONCLUSION: Our study highlighted the potential of personal protective measures against COVID-19 in reducing the transmission of respiratory infections such as ILI. Such findings might be invested during influenza season, particularly among groups at high risk of developing severe complications. Exploring trends detected by the national severe acute respiratory infection surveillance system is recommended to confirm the utility of these measures. | |
| dc.language.iso | EN | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.subject.en | Precautionary measures | |
| dc.subject.en | COVID-19 | |
| dc.subject.en | Influenza-like illness | |
| dc.subject.en | Reduction | |
| dc.subject.en | Non-pharmaceutical interventions | |
| dc.title.en | Practice of non-pharmaceutical interventions against COVID-19 and reduction of the risk of influenza-like illness: a cross-sectional population-based study | |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1186/s40545-022-00450-y | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
| dc.identifier.pubmed | 36042506 | en_US |
| bordeaux.journal | Journal of Pharmaceutical Policy and Practice | en_US |
| bordeaux.volume | 15 | en_US |
| bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
| bordeaux.issue | 1 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| hal.identifier | hal-03834802 | |
| hal.version | 1 | |
| hal.date.transferred | 2022-10-31T08:03:15Z | |
| hal.export | true | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Pharmaceutical%20Policy%20and%20Practice&rft.date=2022-08-30&rft.volume=15&rft.issue=1&rft.eissn=2052-3211%20(Print)%202052-3211&rft.issn=2052-3211%20(Print)%202052-3211&rft.au=YOUSSEF,%20Dalal&ISSA,%20Ola&KANSO,%20Maysaloun&YOUSSEF,%20Janet&ABOU-ABBAS,%20Linda&rft.genre=article |
